Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100270286 | 10027028 | 6 | F | 20120827 | 20160822 | 20140321 | 20160830 | EXP | PHEH2014US005162 | NOVARTIS | 60.79 | YR | F | Y | 90.70000 | KG | 20160830 | CN | COUNTRY NOT SPECIFIED | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100270286 | 10027028 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, DAILY | 161.145004 | MG | Y | S0038 | 22527 | .5 | MG | CAPSULE | QD | ||
| 100270286 | 10027028 | 2 | C | COREG | CARVEDILOL | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 3 | C | CELEBREX | CELECOXIB | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 4 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 5 | C | FEMARA | LETROZOLE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 6 | C | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDETRIAMTERENE | 1 | Unknown | 37.5/25 MG, DAILY | U | 0 | |||||||||
| 100270286 | 10027028 | 7 | C | IBUPROFEN. | IBUPROFEN | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 8 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 9 | C | MOBIC | MELOXICAM | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 10 | C | LETROZOLE. | LETROZOLE | 1 | Unknown | 2.5 MG, DAILY | U | 0 | 2.5 | MG | |||||||
| 100270286 | 10027028 | 11 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 10 MG, BID | U | 0 | 10 | MG | BID | ||||||
| 100270286 | 10027028 | 12 | C | CARVEDILOL. | CARVEDILOL | 1 | Unknown | 25 MG, BID | U | 0 | 25 | MG | BID | ||||||
| 100270286 | 10027028 | 13 | C | HEPARIN | HEPARIN SODIUM | 1 | Subcutaneous | 5000 U, Q12H | U | 0 | 5000 | DF | Q12H | ||||||
| 100270286 | 10027028 | 14 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 20 MG, AT BEDTIME | U | 0 | 20 | MG | |||||||
| 100270286 | 10027028 | 15 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | 17 G, DAILY | U | 0 | 17 | G | |||||||
| 100270286 | 10027028 | 16 | C | BIDIL | HYDRALAZINE HYDROCHLORIDEISOSORBIDE DINITRATE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 17 | C | ELIQUIS | APIXABAN | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 18 | C | LASIX | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 19 | C | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 20 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 21 | C | PROCARDIA | NIFEDIPINE | 1 | Unknown | U | 0 | ||||||||||
| 100270286 | 10027028 | 22 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 100270286 | 10027028 | 1 | Multiple sclerosis |
| 100270286 | 10027028 | 2 | Product used for unknown indication |
| 100270286 | 10027028 | 3 | Product used for unknown indication |
| 100270286 | 10027028 | 4 | Product used for unknown indication |
| 100270286 | 10027028 | 5 | Product used for unknown indication |
| 100270286 | 10027028 | 6 | Product used for unknown indication |
| 100270286 | 10027028 | 7 | Product used for unknown indication |
| 100270286 | 10027028 | 8 | Product used for unknown indication |
| 100270286 | 10027028 | 9 | Product used for unknown indication |
| 100270286 | 10027028 | 10 | Product used for unknown indication |
| 100270286 | 10027028 | 11 | Product used for unknown indication |
| 100270286 | 10027028 | 12 | Product used for unknown indication |
| 100270286 | 10027028 | 13 | Product used for unknown indication |
| 100270286 | 10027028 | 14 | Product used for unknown indication |
| 100270286 | 10027028 | 15 | Constipation |
| 100270286 | 10027028 | 16 | Product used for unknown indication |
| 100270286 | 10027028 | 17 | Product used for unknown indication |
| 100270286 | 10027028 | 18 | Product used for unknown indication |
| 100270286 | 10027028 | 19 | Product used for unknown indication |
| 100270286 | 10027028 | 20 | Product used for unknown indication |
| 100270286 | 10027028 | 21 | Product used for unknown indication |
| 100270286 | 10027028 | 22 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 100270286 | 10027028 | DS |
| 100270286 | 10027028 | HO |
| 100270286 | 10027028 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 100270286 | 10027028 | Aortic valve incompetence | |
| 100270286 | 10027028 | Balance disorder | |
| 100270286 | 10027028 | Binocular eye movement disorder | |
| 100270286 | 10027028 | Blood potassium decreased | |
| 100270286 | 10027028 | Blood pressure decreased | |
| 100270286 | 10027028 | Central nervous system lesion | |
| 100270286 | 10027028 | Cerebrovascular accident | |
| 100270286 | 10027028 | Decreased vibratory sense | |
| 100270286 | 10027028 | Dizziness | |
| 100270286 | 10027028 | Dysarthria | |
| 100270286 | 10027028 | Dyskinesia | |
| 100270286 | 10027028 | Facial pain | |
| 100270286 | 10027028 | Gait disturbance | |
| 100270286 | 10027028 | Gait spastic | |
| 100270286 | 10027028 | Glucose tolerance impaired | |
| 100270286 | 10027028 | Headache | |
| 100270286 | 10027028 | Hemiparesis | |
| 100270286 | 10027028 | High density lipoprotein decreased | |
| 100270286 | 10027028 | Hypertension | |
| 100270286 | 10027028 | Hypoaesthesia | |
| 100270286 | 10027028 | Joint swelling | |
| 100270286 | 10027028 | Knee deformity | |
| 100270286 | 10027028 | Low density lipoprotein increased | |
| 100270286 | 10027028 | Mitral valve incompetence | |
| 100270286 | 10027028 | Muscular weakness | |
| 100270286 | 10027028 | Musculoskeletal discomfort | |
| 100270286 | 10027028 | Neck pain | |
| 100270286 | 10027028 | Neurological symptom | |
| 100270286 | 10027028 | Nuclear magnetic resonance imaging brain abnormal | |
| 100270286 | 10027028 | Optic disc disorder | |
| 100270286 | 10027028 | Osteoarthritis | |
| 100270286 | 10027028 | Pain | |
| 100270286 | 10027028 | Peripheral swelling | |
| 100270286 | 10027028 | Pulmonary valve incompetence | |
| 100270286 | 10027028 | Sleep apnoea syndrome | |
| 100270286 | 10027028 | Speech disorder | |
| 100270286 | 10027028 | Tricuspid valve incompetence | |
| 100270286 | 10027028 | Type 2 diabetes mellitus | |
| 100270286 | 10027028 | Urinary tract infection bacterial | |
| 100270286 | 10027028 | Weight decreased | |
| 100270286 | 10027028 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 100270286 | 10027028 | 1 | 20111011 | 20141025 | 0 |